View in EDS

Developmental and Reproductive Toxicity Testing Strategies for Oligonucleotides: A Workshop Proceedings.

Saved in:
Bibliographic Details
Title: Developmental and Reproductive Toxicity Testing Strategies for Oligonucleotides: A Workshop Proceedings.
Authors: Hannas BR; Eli Lilly & Company, Indianapolis, Indiana, USA., Bender SM; GSK, Collegeville, Pennsylvania, USA., Blasi E; Avidity Biosciences, San Diego, California, USA., Bowman CJ; Pfizer, Inc., Groton, Connecticut, USA., Cavagnaro JA; Access BIO, LC, Boyce, Virginia, USA., Chen CL; Health and Environmental Sciences Institute, Washington, District of Columbia, USA., Coder PS; Charles River Laboratories, Ashland, Ohio, USA., Duijndam B; Dutch Medicines Evaluation Board, Utrecht, Netherlands., Hoberman A; Charles River Laboratories, Horsham, Pennsylvania, USA., Kim TW; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Leconte I; Charles River Laboratories, Lyon, France., Maki K; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Matsumoto M; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Mikashima F; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Misner DL; Aligos Therapeutics, Inc., South San Francisco, California, USA., Mueller L; F. Hoffmann-La Roche, Basel, Switzerland., Powles-Glover N; Regulatory Science Associates, Largs, UK., Rayhon S; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA., Saffarini C; Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA., Siezen C; Dutch Medicines Evaluation Board, Utrecht, Netherlands., Sisler J; Eli Lilly & Company, Indianapolis, Indiana, USA., Wange RL; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., White T; Tacey White Toxicology Consulting, LLC, Philadelphia, Pennsylvania, USA., Templin MV; Charles River Laboratories, Reno, Nevada, USA.
Source: Nucleic acid therapeutics [Nucleic Acid Ther] 2025 Jun; Vol. 35 (3), pp. 93-113. Date of Electronic Publication: 2025 May 30.
Publication Type: Journal Article; Review
Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-3345 (Electronic) Linking ISSN: 21593337 NLM ISO Abbreviation: Nucleic Acid Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40445609
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Developmental and Reproductive Toxicity Testing Strategies for Oligonucleotides: A Workshop Proceedings.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hannas+BR%22">Hannas BR</searchLink>; Eli Lilly & Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Bender+SM%22">Bender SM</searchLink>; GSK, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Blasi+E%22">Blasi E</searchLink>; Avidity Biosciences, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Bowman+CJ%22">Bowman CJ</searchLink>; Pfizer, Inc., Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Cavagnaro+JA%22">Cavagnaro JA</searchLink>; Access BIO, LC, Boyce, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Chen+CL%22">Chen CL</searchLink>; Health and Environmental Sciences Institute, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Coder+PS%22">Coder PS</searchLink>; Charles River Laboratories, Ashland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Duijndam+B%22">Duijndam B</searchLink>; Dutch Medicines Evaluation Board, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoberman+A%22">Hoberman A</searchLink>; Charles River Laboratories, Horsham, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Kim+TW%22">Kim TW</searchLink>; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.<br /><searchLink fieldCode="AU" term="%22Leconte+I%22">Leconte I</searchLink>; Charles River Laboratories, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Maki+K%22">Maki K</searchLink>; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+M%22">Matsumoto M</searchLink>; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mikashima+F%22">Mikashima F</searchLink>; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Misner+DL%22">Misner DL</searchLink>; Aligos Therapeutics, Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Mueller+L%22">Mueller L</searchLink>; F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Powles-Glover+N%22">Powles-Glover N</searchLink>; Regulatory Science Associates, Largs, UK.<br /><searchLink fieldCode="AU" term="%22Rayhon+S%22">Rayhon S</searchLink>; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Saffarini+C%22">Saffarini C</searchLink>; Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Siezen+C%22">Siezen C</searchLink>; Dutch Medicines Evaluation Board, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Sisler+J%22">Sisler J</searchLink>; Eli Lilly & Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Wange+RL%22">Wange RL</searchLink>; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22White+T%22">White T</searchLink>; Tacey White Toxicology Consulting, LLC, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Templin+MV%22">Templin MV</searchLink>; Charles River Laboratories, Reno, Nevada, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101562758%22">Nucleic acid therapeutics</searchLink> [Nucleic Acid Ther] 2025 Jun; Vol. 35 (3), pp. 93-113. <i>Date of Electronic Publication: </i>2025 May 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert%2C+Inc%22">Mary Ann Liebert, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101562758 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-3345 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221593337%22">21593337 </searchLink><i>NLM ISO Abbreviation: </i>Nucleic Acid Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40445609
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1089/nat.2025.0013
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 93
    Titles:
      – TitleFull: Developmental and Reproductive Toxicity Testing Strategies for Oligonucleotides: A Workshop Proceedings.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hannas BR
      – PersonEntity:
          Name:
            NameFull: Bender SM
      – PersonEntity:
          Name:
            NameFull: Blasi E
      – PersonEntity:
          Name:
            NameFull: Bowman CJ
      – PersonEntity:
          Name:
            NameFull: Cavagnaro JA
      – PersonEntity:
          Name:
            NameFull: Chen CL
      – PersonEntity:
          Name:
            NameFull: Coder PS
      – PersonEntity:
          Name:
            NameFull: Duijndam B
      – PersonEntity:
          Name:
            NameFull: Hoberman A
      – PersonEntity:
          Name:
            NameFull: Kim TW
      – PersonEntity:
          Name:
            NameFull: Leconte I
      – PersonEntity:
          Name:
            NameFull: Maki K
      – PersonEntity:
          Name:
            NameFull: Matsumoto M
      – PersonEntity:
          Name:
            NameFull: Mikashima F
      – PersonEntity:
          Name:
            NameFull: Misner DL
      – PersonEntity:
          Name:
            NameFull: Mueller L
      – PersonEntity:
          Name:
            NameFull: Powles-Glover N
      – PersonEntity:
          Name:
            NameFull: Rayhon S
      – PersonEntity:
          Name:
            NameFull: Saffarini C
      – PersonEntity:
          Name:
            NameFull: Siezen C
      – PersonEntity:
          Name:
            NameFull: Sisler J
      – PersonEntity:
          Name:
            NameFull: Wange RL
      – PersonEntity:
          Name:
            NameFull: White T
      – PersonEntity:
          Name:
            NameFull: Templin MV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2159-3345
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Nucleic acid therapeutics
              Type: main
ResultId 1